HK1061564A1 - Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro2,3-b quinolin-4- yl)-2-(2-oxopyrrolidin-1-yl)-acetamide - Google Patents
Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro2,3-b quinolin-4- yl)-2-(2-oxopyrrolidin-1-yl)-acetamideInfo
- Publication number
- HK1061564A1 HK1061564A1 HK04104491.2A HK04104491A HK1061564A1 HK 1061564 A1 HK1061564 A1 HK 1061564A1 HK 04104491 A HK04104491 A HK 04104491A HK 1061564 A1 HK1061564 A1 HK 1061564A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- oxopyrrolidin
- quinolin
- acetamide
- dimethyl
- polymorph forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001121681 | 2001-04-19 | ||
JP2001121682 | 2001-04-19 | ||
PCT/JP2002/003916 WO2002085910A1 (en) | 2001-04-19 | 2002-04-19 | Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1061564A1 true HK1061564A1 (en) | 2004-09-24 |
Family
ID=26613875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04104491.2A HK1061564A1 (en) | 2001-04-19 | 2004-06-21 | Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro2,3-b quinolin-4- yl)-2-(2-oxopyrrolidin-1-yl)-acetamide |
Country Status (11)
Country | Link |
---|---|
US (1) | US6884805B2 (de) |
EP (1) | EP1392696B1 (de) |
JP (1) | JP2004525985A (de) |
KR (1) | KR100909923B1 (de) |
CN (1) | CN100484939C (de) |
AT (1) | ATE492549T1 (de) |
CA (1) | CA2439117C (de) |
DE (1) | DE60238674D1 (de) |
HK (1) | HK1061564A1 (de) |
TW (1) | TWI332503B (de) |
WO (1) | WO2002085910A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004063201A1 (ja) * | 2003-01-08 | 2004-07-29 | Mitsubishi Pharma Corporation | 統合失調症治療剤 |
JP2009525979A (ja) * | 2006-02-07 | 2009-07-16 | 田辺三菱製薬株式会社 | 4−アシルアミノピリジン誘導体を介した神経新生 |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2029497C (en) * | 1989-11-08 | 2002-06-04 | Kunihiro Ninomiya (Deceased) | 4-acylaminopyridine derivative |
-
2002
- 2002-04-19 WO PCT/JP2002/003916 patent/WO2002085910A1/en active Application Filing
- 2002-04-19 CN CNB028071859A patent/CN100484939C/zh not_active Expired - Fee Related
- 2002-04-19 KR KR1020037013682A patent/KR100909923B1/ko not_active IP Right Cessation
- 2002-04-19 CA CA2439117A patent/CA2439117C/en not_active Expired - Fee Related
- 2002-04-19 US US10/475,047 patent/US6884805B2/en not_active Expired - Fee Related
- 2002-04-19 TW TW091108146A patent/TWI332503B/zh not_active IP Right Cessation
- 2002-04-19 DE DE60238674T patent/DE60238674D1/de not_active Expired - Lifetime
- 2002-04-19 EP EP02720521A patent/EP1392696B1/de not_active Expired - Lifetime
- 2002-04-19 AT AT02720521T patent/ATE492549T1/de not_active IP Right Cessation
- 2002-04-19 JP JP2002583437A patent/JP2004525985A/ja active Pending
-
2004
- 2004-06-21 HK HK04104491.2A patent/HK1061564A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI332503B (en) | 2010-11-01 |
DE60238674D1 (de) | 2011-02-03 |
WO2002085910A1 (en) | 2002-10-31 |
EP1392696B1 (de) | 2010-12-22 |
US6884805B2 (en) | 2005-04-26 |
KR20030097833A (ko) | 2003-12-31 |
CA2439117C (en) | 2011-02-08 |
KR100909923B1 (ko) | 2009-07-29 |
CN1498219A (zh) | 2004-05-19 |
EP1392696A1 (de) | 2004-03-03 |
CN100484939C (zh) | 2009-05-06 |
US20040122034A1 (en) | 2004-06-24 |
CA2439117A1 (en) | 2002-10-31 |
JP2004525985A (ja) | 2004-08-26 |
ATE492549T1 (de) | 2011-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20105053B (en) | Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors | |
AP2002002637A0 (en) | Novel piperazine | |
CA2150123A1 (en) | Aminomethylene substituted non-aromatic heterocycles | |
PT1671949E (pt) | Piridinilaminas substituídas | |
MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
MXPA04000278A (es) | Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales. | |
IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
IL142768A0 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
DE60032249D1 (de) | AMINO-SUBSTITUIERTE PYRAZOLOi1,5-Aö-1,5-PYRIMIDINE UND PYRAZOLOi1,5-Aö-1,3,5-TRIAZINE | |
RS20050195A (en) | Heterocyclic substituted piperazines for the treatment of schizophrenia | |
NO970162D0 (no) | Substituerte pyrimidinforbindelser og anvendelse derav | |
YU57603A (sh) | Inhibitori fosfodiesteraze 4 | |
WO2001098268A3 (en) | Piperidine amides as modulators of chemokine receptor activity | |
HU0100973D0 (en) | Use of heteroaryl substituted n-(indole-2-carbonyl)-amide derivatives for the treatment of infections | |
WO2001028987A8 (en) | Benzylcycloalkyl amines as modulators of chemokine receptor activity | |
FI970469A0 (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus | |
BR9609847A (pt) | Derivados de N-(4-Benzila-substituída)-2-aminolactam | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
HK1061564A1 (en) | Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro2,3-b quinolin-4- yl)-2-(2-oxopyrrolidin-1-yl)-acetamide | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
BG105247A (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
MY136138A (en) | Hexacyclic compounds | |
DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser | |
HUP0302928A3 (en) | Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-[n-(4-phenoxyphenyl-carbonyl)amino] pentanamide, process for their production and medicines containing the crystals as the active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20150419 |